Details

Mitochondria-targeting moieties based on N-tethered pyridinium cations
ID Džajić, Ivan (Author), ID Trunkelj, Natalija (Author), ID Repas, Jernej (Author), ID Kandušer, Maša (Author), ID Smrdel, Lara (Author), ID Pajk, Stane (Author), ID Žiberna, Lovro (Author), ID Mlinarič-Raščan, Irena (Author), ID Markelc, Boštjan (Author), ID Omerzel, Maša (Author), ID Jesenko, Tanja (Author), ID Tomašič, Tihomir (Author), ID Peterlin-Mašič, Lucija (Author), ID Cotman, Andrej Emanuel (Author), et al.

.pdfPDF - Presentation file, Download (3,74 MB)
MD5: 7F94C1804BD9E71E43918A01BF954840
URLURL - Source URL, Visit https://onlinelibrary.wiley.com/doi/10.1002/anie.7158257 This link opens in a new window

Abstract
Mitochondria-targeting moieties (MTMs) are molecular fragments designed to deliver covalently tethered functional cargo to mitochondria, providing a modular strategy for chemical biology tools, imaging agents, and mitochondria-targeted therapies. Phosphonium- or nitrogen cation-based MTMs are not inert vectors and exhibit intrinsic bioactivity on mitochondrial and cellular levels to various extents. Here, we systematically evaluated a panel of N+-based cations to determine how structural features influence subcellular distribution and inherent bioactivity. Live-cell imaging of fluorescent dye conjugates revealed that 3,5-diphenylpyridinium (DPPy+) exhibits cellular uptake and mitochondrial targeting comparable to the benchmark triphenylphosphonium (TPP+), whereas conjugates with unsubstituted pyridinium preferentially accumulate in lysosomes. Profiling of inert cargo derivatives showed that DPPy+ has lower intrinsic activity on mitochondrial membrane potential and oxidative phosphorylation, as well as on cellular respiration and viability than TPP+. The combination of efficient mitochondrial delivery and low intrinsic bioactivity translated to bioactive cargo: a Kv1.3 inhibitor conjugate with DPPy+ induced apoptosis in cancer cell lines and demonstrated improved cancer selectivity relative to the TPP+ conjugate in pancreatic organoid models. These results position lipophilic pyridinium cations as effective TPP+ surrogates with enhanced biocompatibility for mitochondria-targeted therapeutic and diagnostic agents, while revealing the structure-dependent competing lysosomal accumulation of permanent nitrogen cations.

Language:English
Keywords:cancer, cations, fluorescentprobes, medicinal chemistry, mitochondria
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
FFA - Faculty of Pharmacy
BF - Biotechnical Faculty
Publication status:Published
Publication version:Version of Record
Year:2026
Number of pages:13 str.
Numbering:Vol. 65, iss. 29 , art. e7158257
PID:20.500.12556/RUL-184316 This link opens in a new window
UDC:615.4:54:616-006
ISSN on article:1521-3773
DOI:10.1002/anie.7158257 This link opens in a new window
COBISS.SI-ID:279001347 This link opens in a new window
Publication date in RUL:03.07.2026
Views:185
Downloads:163
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Angewandte Chemie : international edition
Shortened title:Angew. Chem.
Publisher:Wiley
ISSN:1521-3773
COBISS.SI-ID:21810181 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:rak, kationi, fluorescentne sonde, medicinska kemija, mitohondriji

Projects

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0208
Name:Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P3-0003
Name:Razvoj in ovrednotenje novih terapij za zdravljenje malignih tumorjev

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J7-4635
Name:MitoCan - Predklinični razvoj novih zaviralcev mitohondrijskih ionskih kanalov za zdravljenje raka

Funder:University of Ljubljana
Funding programme:University of Ljubljana start-up programme
Project number:SN-ZRD/22-27/510

Funder:Ministry of Higher Education, Science, and Innovation

Funder:EC - European Commission
Funding programme:European Regional Development Fund
Project number:P20.05187RI-SI-EATRIS

Funder:EC - European Commission
Funding programme:H 2020
Project number:950625
Name:Challenging the Oxidation-State Limitations of the Periodic Table via High-Pressure Fluorine Chemistry
Acronym:HiPeR-F

Funder:HRZZ - Croatian Science Foundation
Funding programme:Croatian Science Foundation (CSF)
Project number:IP-2022-10-2634
Name:The environmental fate of pharmaceuticals of concern: experimental and computational study of degradation products and their ecotoxicological properties

Funder:Italy, Association for Cancer Research
Project number:IF 27271

Funder:Italy, Association for Cancer Research
Project number:fellowship 33493

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back